ALCON INC (2U3.DE) Stock Price, Forecast & Analysis
Europe • Frankfurt Stock Exchange • FRA:2U3 • CH0432492467
2U3.DE Key Statistics, Chart & Performance
The current stock price of 2U3.DE is 65.78 EUR. In the past month the price decreased by -4.56%.
2U3.DE Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 2U3.DE.
2U3.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 2U3.DE. Both the profitability and the financial health of 2U3.DE get a neutral evaluation. Nothing too spectacular is happening here.
2U3.DE Financial Highlights
Over the last trailing twelve months 2U3.DE reported a non-GAAP Earnings per Share(EPS) of 2.52. The EPS decreased by -0.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.28% | ||
| ROA | 3.32% | ||
| ROE | 4.74% | ||
| Debt/Equity | 0.21 |
2U3.DE Forecast & Estimates
19 analysts have analysed 2U3.DE and the average price target is 91.3 EUR. This implies a price increase of 38.8% is expected in the next year compared to the current price of 65.78.
For the next year, analysts expect an EPS growth of 0.91% and a revenue growth 5.17% for 2U3.DE
2U3.DE Ownership
2U3.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EL | ESSILORLUXOTTICA | 31.17 | 118.011B | ||
| 1EL | ESSILORLUXOTTICA | 31.65 | 117.825B | ||
| ESL | ESSILORLUXOTTICA | 31.64 | 117.779B | ||
| GBT | GUERBET | 100.14 | 175.949M | ||
| ALCJ | CROSSJECT | 6.04 | 111.152M | ||
| AFME | CARVOLIX SA | N/A | 110.574M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 47.914M | ||
| SVS | SVAS BIOSANA SPA | 5.78 | 47.712M | ||
| IVN | IVISION TECH SPA | N/A | 15.029M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About 2U3.DE
Company Profile
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
Company Info
ALCON INC
Rue Louis d'Affry 6
Fribourg FRIBOURG CH
Employees: 25599
Phone: 41589113800
ALCON INC / 2U3.DE FAQ
What does ALCON INC do?
Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. The company is headquartered in Fribourg, Fribourg and currently employs 25,599 full-time employees. The company went IPO on 2019-04-09. The firm research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The firm operates in 60 countries and serves consumers and patients in over 140 countries.
What is the stock price of ALCON INC today?
The current stock price of 2U3.DE is 65.78 EUR. The price decreased by -0.63% in the last trading session.
Does ALCON INC pay dividends?
ALCON INC (2U3.DE) has a dividend yield of 0.46%. The yearly dividend amount is currently 0.22.
How is the ChartMill rating for ALCON INC?
2U3.DE has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists 2U3 stock?
2U3.DE stock is listed on the Frankfurt Stock Exchange exchange.
Can you provide the number of employees for ALCON INC?
ALCON INC (2U3.DE) currently has 25599 employees.